Asthma in Patients With Japanese Cedar Pollinosis

被引:0
|
作者
Tanaka, Akihiko [1 ]
Minoguchi, Kenji [2 ]
Pawankar, Ruby [3 ]
Adachi, Mitsuru [1 ]
机构
[1] Showa Univ, Div Allergy & Resp Med, Dept Internal Med, Tokyo, Japan
[2] Sumiregaoka Clin, Yokohama, Kanagawa, Japan
[3] Nippon Med Sch, Tokyo, Japan
来源
关键词
Japanese cedar pollinosis; asthma; allergic rhinitis;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Japanese cedar pollen is the most common causative allergen for seasonal allergic rhinitis (AR) in Japan. More commonly known as Japanese cedar pollinosis, it occurs in spring causing the typical symptoms of seasonal AR, such as sneezing, rhinorrhea, nasal obstruction, nasal itching, and itching of the eyes. Previous reports indicate that the prevalence of Japanese cedar pollinosis among Japanese was 26.5%. According to a more recent questionnaire-based survey, the prevalence of Japanese cedar pollinosis in patients with adult asthma might be up to 30% to 50%, suggesting higher rates than that previously reported. Moreover, 30% to 60% of adult asthmatic patients with concomitant pollinosis have exacer-bations of their asthma symptoms during the Japanese cedar pollen season. These findings suggest that concomitant Japanese cedar pollinosis may be an aggravating factor in patients with asthma. As with other pollens, such as grass and birch, Japanese cedar pollen was shown to be a trigger factor for worsening asthma. In clinical practice, a number of Japanese patients with asthma are mono-sensitized to Japanese cedar pollen but not to other antigens. Further studies are needed to elucidate the mechanisms of Japanese cedar pollen in inducing and in exacerbating asthma. The presence of concomitant AR is often associated with the difficulty in asthma control. However, there has been a controversy whether treating concomitant AR by intranasal corticosteroid would produce better asthma-related outcomes in patients with asthma and AR. The effect of treating concomitant cedar pollinosis by intranasal corticosteroids on asthma control in patients with asthma and cedar pollinosis also remains unknown. Certain systemic treatments, such as leukotriene receptor antagonist and anti-IgE monoclonal antibody, are supposed to reduce the symptoms of both asthma and AR in patients with asthma and concomitant AR. In conclusion, Japanese cedar pollinosis is often associated with exacerbations of asthma. Further investigations are expected to elucidate the precise impact and mechanisms of Japanese cedar pollinosis in asthma.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Sublingual Immunotherapy for Japanese Cedar Pollinosis Attenuates Asthma Exacerbation
    Kikkawa, Sayaka
    Nakagome, Kazuyuki
    Kobayashi, Takehito
    Soma, Tomoyuki
    Kamijo, Atsushi
    Nagata, Makoto
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2019, 11 (03) : 438 - 440
  • [2] Efficacy of Omalizumab in patients with Japanese cedar pollinosis
    Ogino, Satoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2009, 109 : 45P - 45P
  • [3] Influence of daytime sleepiness on pollinosis symptom and QOL in patients with Japanese cedar pollinosis
    Kato, C.
    Takeuchi, N.
    Ito, M.
    Minami, Y.
    Ogino, S.
    Arimoto, H.
    Irifune, M.
    Iwata, N.
    Ookawauchi, I
    Kikumori, H.
    Seo, R.
    Takeda, M.
    Tamaki, A.
    Baba, K.
    Nose, M.
    ALLERGY, 2009, 64 : 334 - 334
  • [4] Approaches to immunotherapies for Japanese cedar pollinosis
    Sakaguchi, Masahiro
    Hirahara, Kazulci
    Fujimura, Takashi
    Toda, Masako
    AURIS NASUS LARYNX, 2011, 38 (04) : 431 - 438
  • [5] Development of immunotherapies for Japanese cedar pollinosis
    Sakaguchi, Masahiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2007, 127 : 69 - 72
  • [6] Seasonal change of bronchial inflammatory condition in patients with asthma and comorbid Japanese cedar pollinosis in pollen season
    Soma, T.
    Hoshi, R.
    Nakagome, K.
    Masumoto, A.
    Uchida, Y.
    Kobayashi, T.
    Hagiwara, K.
    Kanazawa, M.
    Nagata, M.
    ALLERGY, 2013, 68 : 28 - 28
  • [7] Validation studies of the OHIO Chamber in patients with Japanese cedar pollinosis
    Hashiguchi, K.
    Tang, H.
    Suematsu, K.
    Tsubaki, S.
    Gotoh, M.
    Okubo, K.
    ALLERGY, 2008, 63 : 345 - 345
  • [8] Validation Study of the OHIO Chamber in Patients with Japanese Cedar Pollinosis
    Hashiguchi, Kazuhiro
    Tang, Huaipeng
    Fujita, Toshio
    Suematsu, Kiyochika
    Tsubaki, Shigekazu
    Nagakura, Hitoshi
    Kitajima, Sei
    Gotoh, Minoru
    Okubo, Kimihiro
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2009, 149 (02) : 141 - 149
  • [9] Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis
    Kikuoka, Hirotaka
    Kouzaki, Hideaki
    Matsumoto, Koji
    Arai, Hiroyuki
    Yamamoto, Sayuri
    Tojima, Ichiro
    Shimizu, Shino
    Miyashita, Hiromi
    Ogawa, Yukiko
    Osada, Toshihiro
    Okano, Mitsuhiro
    Yuta, Atsushi
    Shimizu, Takeshi
    CLINICAL IMMUNOLOGY, 2020, 210
  • [10] Correlation of Japanese cedar pollen and Japanese cypress pollen major allergen IgE levels in patients with Japanese cedar pollinosis
    Suzuki, Keisuke
    Kobayashi, Satoko
    Lund, Kaare
    Ohashi-Doi, Katsuyo
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1037 - 1037